Drug Database
SL
SLITonePLUS (SLITonePLUS Birch / Itulatek / SLITonePLUS)
✓ ApprovedALK-Abello · therapeutic agent
What is SLITonePLUS?
SLITonePLUS is a therapeutic agent developed by ALK-Abello. It is approved for therapeutic indications via oral (po) or sublingual (sl)/oral transmucosal.
Drug Profile
| Brand Names | SLITonePLUS Birch, Itulatek, SLITonePLUS |
| Company | ALK-Abello |
| Route | Oral (PO), Sublingual (SL)/Oral Transmucosal |
| Status | Approved |
Sources: ClinicalTrials.gov, ALK-Abello
Therapeutic Indications
SLITonePLUS is developed for 1 unique indication across 1 therapeutic area.
| Therapeutic Area | Condition | Phase |
|---|---|---|
| Immune system disorders | Hypersensitivity | ✓ Approved |